BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pu D, Zhang Z, Feng B. Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases. Front Pharmacol 2022;13:906419. [DOI: 10.3389/fphar.2022.906419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Balderramo D. Role of the combination of biologics and/or small molecules in the treatment of patients with inflammatory bowel disease. World J Gastroenterol 2022; 28(47): 6743-6751 [DOI: 10.3748/wjg.v28.i47.6743] [Reference Citation Analysis]
2 Wang J, Zhang P, Chen S, Duan H, Xie L. Microbiota and Gut Health: Promising Prospects for Clinical Trials from Bench to Bedside. Advanced Gut & Microbiome Research 2022;2022:1-17. [DOI: 10.1155/2022/2290052] [Reference Citation Analysis]
3 Fabozzi G, Rebuzzini P, Cimadomo D, Allori M, Franzago M, Stuppia L, Garagna S, Ubaldi FM, Zuccotti M, Rienzi L. Endocrine-Disrupting Chemicals, Gut Microbiota, and Human (In)Fertility—It Is Time to Consider the Triad. Cells 2022;11:3335. [DOI: 10.3390/cells11213335] [Reference Citation Analysis]
4 Penagini F, Calcaterra V, Dilillo D, Vandoni M, Gianolio L, Gatti A, Rendo G, Giuriato M, Cococcioni L, De Silvestri A, Zuccotti G. Self-Perceived Physical Level and Fitness Performance in Children and Adolescents with Inflammatory Bowel Disease. Children 2022;9:1399. [DOI: 10.3390/children9091399] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Ghosh S, Moorthy B, Haribabu B, Jala VR. Cytochrome P450 1A1 is essential for the microbial metabolite, Urolithin A-mediated protection against colitis. Front Immunol 2022;13:1004603. [DOI: 10.3389/fimmu.2022.1004603] [Reference Citation Analysis]